HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zengli Yu Selected Research

Cleft Palate (Palate, Cleft)

5/2021LncRNA Meg3-mediated regulation of the Smad pathway in atRA-induced cleft palate.
1/2021The role of MEG3 in the proliferation of palatal mesenchymal cells is related to the TGFβ/Smad pathway in TCDD inducing cleft palate.
1/2021Correlation between TGF-β2/3 promoter DNA methylation and Smad signaling during palatal fusion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
1/2020Oct4 plays a role in 2, 3, 7, 8 - tetrachlorobenzo-p-dioxin (TCDD) inducing cleft palate and inhibiting mesenchymal proliferation.
1/2020TCDD inhibited the osteogenic differentiation of human fetal palatal mesenchymal cells through AhR and BMP-2/TGF-β/Smad signaling.
5/2016TCDD promoted EMT of hFPECs via AhR, which involved the activation of EGFR/ERK signaling.
1/2016Effect of TCDD on the fate of epithelial cells isolated from human fetal palatal shelves (hFPECs).
1/2015Association between Maternal MTHFR Polymorphisms and Nonsyndromic Cleft Lip with or without Cleft Palate in Offspring, A Meta-Analysis Based on 15 Case-Control Studies.
6/2011Inhibition of Smad signaling is implicated in cleft palate induced by all-trans retinoic acid.
2/2006All-trans retinoic acid inhibited chondrogenesis of mouse embryonic palate mesenchymal cells by down-regulation of TGF-beta/Smad signaling.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zengli Yu Research Topics

Disease

11Cleft Palate (Palate, Cleft)
05/2021 - 02/2005
8Neoplasms (Cancer)
05/2022 - 11/2004
6Inflammation (Inflammations)
01/2022 - 01/2018
4Insulin Resistance
05/2022 - 01/2018
4Body Weight (Weight, Body)
06/2020 - 01/2014
4Breast Neoplasms (Breast Cancer)
11/2005 - 01/2003
3Chronic Disease (Chronic Diseases)
01/2022 - 01/2020
3Colonic Neoplasms (Colon Cancer)
07/2006 - 11/2004
2Cardiovascular Diseases (Cardiovascular Disease)
05/2022 - 01/2020
2Cognitive Dysfunction
04/2022 - 12/2021
2Obesity
07/2021 - 01/2018
2Congenital Abnormalities (Deformity)
01/2021 - 01/2015
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 11/2020
2Hypertension (High Blood Pressure)
01/2020 - 01/2019
1Pregnancy Complications
08/2022
1Glucose Metabolism Disorders
05/2022
1Hepatoblastoma
03/2022
1Chronic Hepatitis B
03/2022
1Neoplasm Metastasis (Metastasis)
03/2022
1Liver Diseases (Liver Disease)
03/2022
1Atrial Heart Septal Defects (Atrial Septal Defect)
01/2022
1Abdominal Obesity
01/2022
1Premature Birth (Birth, Premature)
01/2022
1Overweight
07/2021
1Ovarian Hyperstimulation Syndrome
07/2021
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2021
1Prediabetic State (Prediabetes)
07/2021
1Stillbirth
06/2021
1Chronic Obstructive Pulmonary Disease (COPD)
01/2021
1COVID-19
01/2021
1Colitis
01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
11/2020
1Huntington Disease (Huntington's Disease)
11/2020
1Gestational Diabetes (Gestational Diabetes Mellitus)
06/2020
1Respiratory Sounds (Crackle)
01/2020
1Asthma (Bronchial Asthma)
01/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Chronic Renal Insufficiency
01/2019
1Iron Deficiencies
01/2019
1Anemia
12/2017

Drug/Important Bio-Agent (IBA)

8Polychlorinated Dibenzodioxins (TCDD)IBA
01/2021 - 06/2004
5Particulate MatterIBA
08/2022 - 01/2020
4Estrogens (Estrogen)FDA Link
11/2005 - 01/2003
3Glucose (Dextrose)FDA LinkGeneric
05/2022 - 01/2018
3Biological ProductsIBA
03/2022 - 01/2020
3Tretinoin (Retinoic Acid)FDA LinkGeneric
06/2011 - 02/2005
3GenisteinIBA
08/2005 - 03/2003
2Folic Acid (Vitamin M)FDA LinkGeneric
05/2022 - 01/2020
2Insulin (Novolin)FDA Link
05/2022 - 01/2022
2ZincIBA
05/2022 - 06/2002
2Biomarkers (Surrogate Marker)IBA
03/2022 - 01/2018
2Air Pollutants (Pollutants, Air)IBA
01/2022 - 06/2021
2Environmental Pollutants (Pollutants, Environmental)IBA
06/2021 - 06/2004
2CytokinesIBA
01/2021 - 01/2018
2Proteins (Proteins, Gene)FDA Link
01/2021 - 11/2020
2LipopolysaccharidesIBA
11/2020 - 05/2008
2DioxinsIBA
01/2020 - 01/2015
2Triglycerides (Triacylglycerol)IBA
01/2019 - 01/2018
2Messenger RNA (mRNA)IBA
08/2005 - 06/2004
1Vitamin B 6IBA
05/2022
1Advanced Glycation End ProductsIBA
04/2022
1Circular RNAIBA
03/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1C-Reactive ProteinIBA
01/2022
1Dietary Advanced Glycation End ProductsIBA
12/2021
1Metformin (Glucophage)FDA LinkGeneric
07/2021
1Sulfur DioxideIBA
06/2021
1Nitrogen DioxideIBA
06/2021
1Carbon MonoxideIBA
06/2021
1OzoneIBA
06/2021
1ORALIT (ORS)IBA
06/2021
1Long Noncoding RNAIBA
05/2021
1Smad2 ProteinIBA
05/2021
1LactoferrinIBA
01/2021
1Persistent Organic PollutantsIBA
01/2021
1jugloneIBA
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1GoldIBA
01/2021
1VaccinesIBA
01/2021
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2021
1Transforming Growth Factor beta (TGF-beta)IBA
01/2021
1Dextran SulfateIBA
01/2021
1Interleukin-10 (Interleukin 10)IBA
01/2021
1InterleukinsIBA
01/2021
1Polysaccharides (Glycans)IBA
11/2020
1Corn Oil (Oil, Corn)IBA
06/2020
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
01/2020
11,4-dioxinIBA
01/2020
1HDL LipoproteinsIBA
01/2019
1IronIBA
01/2019
1CholesterolIBA
01/2018
1Insulin Receptor Substrate ProteinsIBA
01/2018
1CCR2 ReceptorsIBA
01/2018
1LDL CholesterolIBA
01/2018
1HDL CholesterolIBA
01/2018
1LipidsIBA
01/2018
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2018
1ResveratrolIBA
01/2018
1Hemoglobins (Hemoglobin)IBA
12/2017
1Eosine Yellowish-(YS) (Eosin)IBA
01/2017